BUFFALO, N.Y.--(BUSINESS WIRE)--Allient Inc. (Nasdaq: ALNT) Announces Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast.

In the fourth quarter, Revolve's stock rose as its revenue met expectations with a 4.4% year-over-year increase. In fiscal second quarter 2026, Haemonetics delivered strong performance, raising guidance and posting margin gains that signal operational discipline. CHWY shares declined in September after the company reported elevated selling, general, and administrative expenses.

Allient (ALNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Stocks making new highs Friday are industrial sector companies Allient and Wabtec and health technology company Penumbra.

Allient (ALNT) could produce exceptional returns because of its solid growth attributes.

Industrial tech stock Allient is currently flashing a bullish signal as it eyes a fresh entry amid a powerful run.

Boston Partners lowered its position in Allient Inc. (NASDAQ: ALNT) by 33.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,259 shares of the company's stock after selling 3,676 shares during the period. Boston Partners' holdings in Allient were worth $264,000 at

Allient (ALNT) could produce exceptional returns because of its solid growth attributes.

PARR, AU, GMED, ALNT and SNDK emerge as top picks after posting gains, rising estimates and sustained relative price outperformance.

Allient (ALNT) could produce exceptional returns because of its solid growth attributes.